AKYA

Akoya Biosciences Inc

LABORATORY ANALYTICAL INSTRUMENTS
LIFE SCIENCES

Prices are adjusted according to historical splits.

Akoya Biosciences Inc Stock Price

Vitals

Today's Low:
$13.3200
Today's High:
$14.0400
Open Price:
$13.8300
52W Low:
$8.02
52W High:
$16.57
Prev. Close:
$13.9200
Volume:
94829

Company Statistics

Market Cap.:
$0.505 billion
Book Value:
2.406
Revenue TTM:
$0.064 billion
Operating Margin TTM:
-91.7%
Gross Profit TTM:
$0.034 billion
Gross Profit TTM:
$0.034 billion
Profit Margin:
-98.1%
Return on Assets TTM:
-18.9%
Return on Equity TTM:
-52.9%

Company Profile

Akoya Biosciences Inc had its IPO on 2021-04-16 under the ticker symbol AKYA.

The company operates in the LIFE SCIENCES sector and LABORATORY ANALYTICAL INSTRUMENTS industry. Akoya Biosciences Inc has a staff strength of 0 employees.

Stock update

Shares of Akoya Biosciences Inc opened at $13.83 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $13.32 - $14.04, and closed at $13.32.

This is a -4.31% slip from the previous day's closing price.

A total volume of 94,829 shares were traded at the close of the day’s session.

In the last one week, shares of Akoya Biosciences Inc have increased by +2.46%.

Akoya Biosciences Inc's Key Ratios

Akoya Biosciences Inc has a market cap of $0.505 billion, indicating a price to book ratio of 5.7 and a price to sales ratio of 7.83.

In the last 12-months Akoya Biosciences Inc’s revenue was $0.064 billion with a gross profit of $0.034 billion and an EBITDA of $-0.053 billion. The EBITDA ratio measures Akoya Biosciences Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Akoya Biosciences Inc’s operating margin was -91.7% while its return on assets stood at -18.9% with a return of equity of -52.9%.

In Q2, Akoya Biosciences Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 36.9%.

Akoya Biosciences Inc’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
None

Its diluted EPS in the last 12-months stands at $-1.439 per share while it has a forward price to earnings multiple of - and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Akoya Biosciences Inc’s profitability.

Akoya Biosciences Inc stock is trading at a EV to sales ratio of 7.55 and a EV to EBITDA ratio of -9.0. Its price to sales ratio in the trailing 12-months stood at 7.83.

Akoya Biosciences Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Akoya Biosciences Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Akoya Biosciences Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Akoya Biosciences Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Akoya Biosciences Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Akoya Biosciences Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$13.32
52-Week High
$16.57
52-Week Low
$8.02
Analyst Target Price
$19.67

Akoya Biosciences Inc stock is currently trading at $13.32 per share. It touched a 52-week high of $16.57 and a 52-week low of $16.57. Analysts tracking the stock have a 12-month average target price of $19.67.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Akoya Biosciences Inc

The stock symbol (also called stock or share ticker) of Akoya Biosciences Inc is AKYA

The IPO of Akoya Biosciences Inc took place on 2021-04-16

Similar Industry Stocks (LABORATORY ANALYTICAL INSTRUMENTS)

Last Price
Chg
Chg%
$1.97
-0.24
-10.86%
$2.49
-0.13
-4.96%
$10.25
-0.93
-8.32%
$2.23
-0.15
-6.3%
$8.08
-0.73
-8.29%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Akoya Biosciences, Inc., a life sciences technology company, offers space biology solutions focused on transforming discovery and clinical research. The company is headquartered in Marlborough, Massachusetts.

Address

100 CAMPUS DRIVE, 6TH FLOOR, MARLBOROUGH, MA, US